{
  "actions": [
    {
      "acted_at": "2020-03-19",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2020-03-19",
      "action_code": "",
      "committees": [
        "SSFI"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Finance.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s3537-116",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Finance",
      "committee_id": "SSFI"
    }
  ],
  "congress": "116",
  "cosponsors": [
    {
      "bioguide_id": "B001243",
      "district": null,
      "name": "Blackburn, Marsha",
      "original_cosponsor": true,
      "sponsored_at": "2020-03-19",
      "state": "TN",
      "title": "Sen.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "C001098",
      "district": null,
      "name": "Cruz, Ted",
      "original_cosponsor": true,
      "sponsored_at": "2020-03-19",
      "state": "TX",
      "title": "Sen.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2020-03-19",
  "number": "3537",
  "official_title": "A bill to require the Secretary of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the United States, to ban the use of Federal funds for the purchase of drugs manufactured in China, and for other purposes.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "hr6482-116",
      "identified_by": "CRS",
      "reason": "identical",
      "type": "bill"
    },
    {
      "bill_id": "s3635-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    }
  ],
  "short_title": "Protecting Our Pharmaceutical Supply Chain from China Act of 2020",
  "sponsor": {
    "bioguide_id": "C001095",
    "district": null,
    "name": "Cotton, Tom",
    "state": "AR",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2020-03-19",
  "subjects": [
    "Asia",
    "Business expenses",
    "China",
    "Drug safety, medical device, and laboratory regulation",
    "Government information and archives",
    "Health",
    "Health care costs and insurance",
    "Health programs administration and funding",
    "Health technology, devices, supplies",
    "Income tax deductions",
    "Manufacturing",
    "Military medicine",
    "Military procurement, research, weapons development",
    "Prescription drugs",
    "Public contracts and procurement",
    "Trade restrictions",
    "Veterans' medical care"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2020-03-19",
    "date": "2021-09-08T19:43:59Z",
    "text": "Protecting Our Pharmaceutical Supply Chain from China Act of 2020\n\nThis bill requires the federal government to maintain a registry of certain foreign-sourced drugs, prohibits federal health care programs from purchasing drugs containing Chinese ingredients, requires drugs to be labeled for country of origin, and offers domestic manufacturing facility tax incentives."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Protecting Our Pharmaceutical Supply Chain from China Act of 2020",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Protecting Our Pharmaceutical Supply Chain from China Act of 2020",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to require the Secretary of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the United States, to ban the use of Federal funds for the purchase of drugs manufactured in China, and for other purposes.",
      "type": "official"
    }
  ],
  "updated_at": "2022-02-08T23:15:31Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/s/BILLSTATUS-116s3537.xml"
}